Pilot Study of Velcade® in IgA Nephropathy

NCT01103778 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease
IgA Nephropathy

Interventions

DRUG: Bortezomib (Velcade®)

Sponsor

The Rogosin Institute

Collaborators

[object Object]